Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Completes Brahms Buy

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has completed its $471 million acquisition of German diagnostics firm Brahms, the firm said today.

Thermo Fisher initially announced the deal in early September. The acquisition will complement its immunoassay test portfolio and expand its reagent manufacturing capabilities in Europe.

Brahms, based in Henningsdorf, Germany, makes tests based on biomarkers for sepsis, cardiovascular, and pulmonary diseases, as well as intensive care treatments and prenatal screening products. The firm has around 400 employees in 65 countries worldwide and had 2008 annual revenues of approximately $105 million.

Thermo said that Brahms will be integrated into its Analytical Technologies segment. It will use Brahms' former headquarters in Hennigsdorf, Germany, as the European Center of Excellence for its clinical diagnostics business.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.